文献速递临床免疫分子诊断

新型多重酶联免疫吸附试验检测巨细胞病毒UL144 IgG血清反应性

A Novel Multiplexed Enzyme-Linked Immunosorbent Assay for the Detection of IgG Seroreactivity to Cytomegalovirus (CMV) UL144.
PubMed 文献 · J Clin Microbiol · 2021-07-19

本研究开发了一种以CMV UL144蛋白为抗原的多重ELISA,用于检测抗CMV UL144 IgG。用55份CMV IgG阳性和59份阴性血清优化,确定阈值0.1,在303份血清中评估:敏感性86.72%、特异性96.57%、阳性预测值94.40%、阴性预测值91.60%。该法简单重复性好,无HSV交叉反应,有助于区分自然感染与缺乏UL144的CMV疫苗,并可用于CMV毒株流行病学研究。

要点

  • 基于UL144 A、B、C基因型的多重ELISA可检测抗CMV UL144 IgG。
  • 在303份血清中敏感性86.72%、特异性96.57%。
  • 与HSV阳性CMV阴性血清无交叉反应。

核心结论

  • 该多重ELISA能简单、可重复地检测抗CMV UL144 IgG,可能有助于区分自然感染与缺乏UL144的CMV疫苗,并为CMV毒株流行病学研究提供工具。

研究设计与样本

  • 研究开发了以CMV UL144 A、B、C蛋白为抗原的多重ELISA,用55份CMV IgG阳性和59份阴性血清进行优化,并在总共303份血清中评估性能。

主要发现

  • 以0.1为阈值,多重ELISA总体敏感性86.72%(95%CI 79.59%~92.07%),特异性96.57%(95%CI 92.69%~98.73%)。
  • 阳性预测值94.40%(95%CI 88.45%~97.38%),阴性预测值91.60%(95%CI 87.50%~94.44%)。
  • 批间和批内中位变异系数分别为0.06(IQR 0.56,0.2)和0.171(IQR 0.038,0.302)。
  • 与HSV阳性CMV阴性血清无交叉反应。

关键数值与推荐

  • 检测阈值设为0.1(光密度值)。
  • 在303份血清中,敏感性86.72%(95%CI 79.59%~92.07%),特异性96.57%(95%CI 92.69%~98.73%)。

临床怎么用

  • 该ELISA可用于检测抗CMV UL144 IgG,辅助区分自然感染与缺乏UL144的CMV疫苗免疫。
  • 可用于CMV毒株的流行病学研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infection with human cytomegalovirus (CMV) is common and may have grave consequences in transplant recipients and congenitally infected children. Diagnosis of CMV infection is based on detection of specific antibodies and molecular assays. The incorporation of CMV serological assays into diagnostic algorithms requires careful evaluation and interpretation. Very few serological assays measure CMV infection by a specific strain. We developed an enzyme-linked immunosorbent assay (ELISA) using CMV-encoded UL144 as the antigen. UL144 encodes three major genotypes, A, B, and C, and recombinants. The ELISA was developed with the three UL144 proteins and optimized as a multiplex assay. Sera from 55 positive and 59 negative CMV IgG, determined by the clinical microbiology laboratory, were used for evaluation and optimization. A cutoff optical density (OD) that distinguishes UL144 antibody-positive from antibody-negative sera was established. UL144 A, B, C, and combinations of these antigens were detected in sera. An assay threshold of 0.1 was established and, from a total of 303 sera, the overall sensitivity, specificity, and positive and negative predictive values of the multiplex ELISA were 86.72% (95% confidence interval [CI] 79.59% to 92.07%), 96.57% (92.69% to 98.73%), 94.40% (88.45% to 97.38%), and 91.60% (87.50% to 94.44%), respectively. The inter- and intraassay median coefficients of variation were 0.06 (interquartile range [IQR] 0.56, 0.2) and 0.171 (IQR 0.038, 0.302), respectively. No cross-reactivity was observed with HSV-positive CMV-negative sera. This ELISA gives simple and reproducible results for detection of anti-CMV UL144 IgG. It may assist in differentiating natural infection from CMV vaccines that lack UL144, and may provide an important tool for epidemiological studies of CMV strains.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Miller H, Simpson P, Forman M, et al. A Novel Multiplexed Enzyme-Linked Immunosorbent Assay for the Detection of IgG Seroreactivity to Cytomegalovirus (CMV) UL144. J Clin Microbiol. 2021. PMID: 34076473. doi:10.1128/JCM.00964-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。